{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:48:47Z","timestamp":1787579327433,"version":"build-2736575974"},"reference-count":38,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2019.8129","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T05:46:57Z","timestamp":1571982417000},"source":"Crossref","is-referenced-by-count":2,"title":["Population pharmacokinetics of tacrolimus in pediatric patients with systemic\u2011onset juvenile idiopathic arthritis: Initial dosage recommendations"],"prefix":"10.3892","author":[{"given":"Dongdong","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Children's Hospital of Fudan University, Shanghai 201102, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Children's Hospital of Fudan University, Shanghai 201102, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, Children's Hospital of Fudan University, Shanghai 201102, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Children's Hospital of Fudan University, Shanghai 201102, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2019,10,25]]},"reference":[{"key":"key20200713101501_b1-etm-0-0-8129","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/acr.23277","article-title":"Effect of biologic therapy on clinical and laboratory features of macrophage activation syndrome associated with systemic juvenile idiopathic arthritis","volume":"70","author":"Schulert","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"key20200713101501_b2-etm-0-0-8129","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.autrev.2016.07.004","article-title":"Systemic-onset juvenile idiopathic arthritis","volume":"15","author":"Cimaz","year":"2016","journal-title":"Autoimmun Rev"},{"key":"key20200713101501_b3-etm-0-0-8129","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/rheumatology\/kei172","article-title":"Safety of tacrolimus, an immunosuppressive agent, in the treatment of rheumatoid arthritis in elderly patients","volume":"45","author":"Kawai","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"key20200713101501_b4-etm-0-0-8129","first-page":"243","article-title":"Efficacy and safety of tacrolimus (FK506) in treatment of rheumatoid arthritis: A randomized, double blind, placebo controlled dose-finding study","volume":"31","author":"Kondo","year":"2004","journal-title":"J Rheumatol"},{"key":"key20200713101501_b5-etm-0-0-8129","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10067-008-1066-y","article-title":"Successful treatment of pyoderma gangrenosum associated with juvenile idiopathic arthritis with a combination of topical tacrolimus and oral prednisolone","volume":"28","author":"Chandrasekhara","year":"2009","journal-title":"Clin Rheumatol"},{"key":"key20200713101501_b6-etm-0-0-8129","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1093\/rheumatology\/keu297","article-title":"Treatment of refractory polyarticular juvenile idiopathic arthritis with tacrolimus","volume":"53","author":"Shimizu","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"key20200713101501_b7-etm-0-0-8129","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s00431-006-0380-0","article-title":"Treatment of difficult cases of systemic-onset juvenile idiopathic arthritis with tacrolimus","volume":"166","author":"Tanaka","year":"2007","journal-title":"Eur J Pediatr"},{"key":"key20200713101501_b8-etm-0-0-8129","first-page":"2305","article-title":"Treatment of patients with systemic-onset juvenile idiopathic arthritis with tacrolimus","volume":"17","author":"Wang","year":"2019","journal-title":"Exp Ther Med"},{"key":"key20200713101501_b9-etm-0-0-8129","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/00007691-199512000-00009","article-title":"Consensus document: Therapeutic monitoring of tacrolimus (FK-506)","volume":"17","author":"Jusko","year":"1995","journal-title":"Ther Drug Monit"},{"key":"key20200713101501_b10-etm-0-0-8129","doi-asserted-by":"publisher","first-page":"404","DOI":"10.2165\/00003088-199529060-00003","article-title":"Clinical pharmacokinetics of tacrolimus","volume":"29","author":"Venkataramanan","year":"1995","journal-title":"Clin Pharmacokinet"},{"key":"key20200713101501_b11-etm-0-0-8129","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/jcpt.12396","article-title":"Population pharmacokinetics of tacrolimus in Thai kidney transplant patients: Comparison with similar data from other populations","volume":"41","author":"Vadcharavivad","year":"2016","journal-title":"J Clin Pharm Ther"},{"key":"key20200713101501_b12-etm-0-0-8129","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2165\/11594760-000000000-00000","article-title":"Population pharmacokinetic modelling and design of a Bayesian estimator for therapeutic drug monitoring of tacrolimus in lung transplantation","volume":"51","author":"Monchaud","year":"2012","journal-title":"Clin Pharmacokinet"},{"key":"key20200713101501_b13-etm-0-0-8129","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/FTD.0b013e3181aab02b","article-title":"Population pharmacokinetics of tacrolimus in pediatric hematopoietic stem cell transplant recipients: New initial dosage suggestions and a model-based dosage adjustment tool","volume":"31","author":"Wallin","year":"2009","journal-title":"Ther Drug Monit"},{"key":"key20200713101501_b14-etm-0-0-8129","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3109\/00498254.2015.1021733","article-title":"Effects of CYP3A5 genotypes, ABCB1 C3435T and G2677T\/A polymorphism on pharmacokinetics of Tacrolimus in Chinese adult liver transplant patients","volume":"45","author":"Zhu","year":"2015","journal-title":"Xenobiotica"},{"key":"key20200713101501_b15-etm-0-0-8129","doi-asserted-by":"publisher","first-page":"75","DOI":"10.5414\/CP202189","article-title":"Population pharmacokinetic analysis of tacrolimus early after Chinese pediatric liver transplantation","volume":"53","author":"Yang","year":"2015","journal-title":"Int J Clin Pharmacol Ther"},{"key":"key20200713101501_b16-etm-0-0-8129","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/FTD.0b013e31829dcbcd","article-title":"Population pharmacokinetic analysis of tacrolimus early after pediatric liver transplantation","volume":"36","author":"Musuamba","year":"2014","journal-title":"Ther Drug Monit"},{"key":"key20200713101501_b17-etm-0-0-8129","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/aps.2014.110","article-title":"A population pharmacokinetic study of tacrolimus in healthy Chinese volunteers and liver transplant patients","volume":"36","author":"Lu","year":"2015","journal-title":"Acta Pharmacol Sin"},{"key":"key20200713101501_b18-etm-0-0-8129","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/FTD.0000000000000134","article-title":"Development of a population PK model of tacrolimus for adaptive dosage control in stable kidney transplant patients","volume":"37","author":"Andreu","year":"2015","journal-title":"Ther Drug Monit"},{"key":"key20200713101501_b19-etm-0-0-8129","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/FTD.0b013e31829f1ab8","article-title":"Population pharmacokinetics of tacrolimus in adult kidney transplant patients: Impact of CYP3A5 genotype on starting dose","volume":"36","author":"Bergmann","year":"2014","journal-title":"Ther Drug Monit"},{"key":"key20200713101501_b20-etm-0-0-8129","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/bcpt.12176","article-title":"Population pharmacokinetic-pharmacogenetic model of tacrolimus in the early period after kidney transplantation","volume":"114","author":"Han","year":"2014","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"key20200713101501_b21-etm-0-0-8129","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/jcpt.12828","article-title":"Wuzhi capsule and haemoglobin influence tacrolimus elimination in paediatric kidney transplantation patients in a population pharmacokinetics analysis: A retrospective study","volume":"44","author":"Wang","year":"2019","journal-title":"J Clin Pharm Ther"},{"key":"key20200713101501_b22-etm-0-0-8129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00498254.2019.1651419","article-title":"Population pharmacokinetics and dosing regimen optimization of tacrolimus in Chinese pediatric hematopoietic stem cell transplantation patients","author":"Wang","year":"2019","journal-title":"Xenobiotica"},{"key":"key20200713101501_b23-etm-0-0-8129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00498254.2019.1651419","article-title":"Model extrapolation to a real-world dataset: Evaluation of tacrolimus population pharmacokinetics and drug interaction in pediatric liver transplantation patients","author":"Wang","year":"2019","journal-title":"Xenobiotica"},{"key":"key20200713101501_b24-etm-0-0-8129","first-page":"4023","article-title":"Population pharmacokinetics of tacrolimus in pediatric refractory nephrotic syndrome and a summary of other pediatric disease models","volume":"17","author":"Wang","year":"2019","journal-title":"Exp Ther Med"},{"key":"key20200713101501_b25-etm-0-0-8129","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev.pharmtox.48.113006.094708","article-title":"Mechanism-based concepts of size and maturity in pharmacokinetics","volume":"48","author":"Anderson","year":"2008","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"key20200713101501_b26-etm-0-0-8129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00498254.2019.1651419","article-title":"Population pharmacokinetics and initial dosing regimen optimization of cyclosporin in pediatric hemophagocytic lymphohistiocytosis patients","author":"Wang","year":"2019","journal-title":"Xenobiotica"},{"key":"key20200713101501_b27-etm-0-0-8129","first-page":"2412","article-title":"Population pharmacokinetics of sirolimus in pediatric patients with kaposiform hemangioendothelioma: A retrospective study","volume":"18","author":"Wang","year":"2019","journal-title":"Oncol Lett"},{"key":"key20200713101501_b28-etm-0-0-8129","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.diagmicrobio.2006.06.013","article-title":"Population pharmacokinetic modeling and Monte Carlo simulation of varying doses of intravenous metronidazole","volume":"55","author":"Sprandel","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key20200713101501_b29-etm-0-0-8129","first-page":"CD001533","article-title":"Corticosteroid therapy for nephrotic syndrome in children","author":"Hahn","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"key20200713101501_b30-etm-0-0-8129","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1007\/s10067-006-0256-8","article-title":"Leukocytapheresis for the treatment of refractory systemic-onset juvenile idiopathic arthritis","volume":"26","author":"Tanaka","year":"2007","journal-title":"Clin Rheumatol"},{"key":"key20200713101501_b31-etm-0-0-8129","first-page":"935","article-title":"Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis","volume":"32","author":"Kimura","year":"2005","journal-title":"J Rheumatol"},{"key":"key20200713101501_b32-etm-0-0-8129","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1002\/art.10885","article-title":"Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type","volume":"48","author":"Quartier","year":"2003","journal-title":"Arthritis Rheum"},{"key":"key20200713101501_b33-etm-0-0-8129","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/j.1523-1755.2005.00461.x","article-title":"Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: An open-labeled pilot study","volume":"68","author":"Mok","year":"2005","journal-title":"Kidney Int"},{"key":"key20200713101501_b34-etm-0-0-8129","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2165\/00003088-199223010-00002","article-title":"Pharmacokinetic studies in paediatric patients. Clinical and ethical considerations","volume":"23","author":"Kauffman","year":"1992","journal-title":"Clin Pharmacokinet"},{"key":"key20200713101501_b35-etm-0-0-8129","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1460-9592.2011.03536.x","article-title":"Tips and traps analyzing pediatric PK data","volume":"21","author":"Anderson","year":"2011","journal-title":"Paediatr Anaesth"},{"key":"key20200713101501_b36-etm-0-0-8129","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2165\/00003088-199630050-00001","article-title":"A size standard for pharmacokinetics","volume":"30","author":"Holford","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"key20200713101501_b37-etm-0-0-8129","doi-asserted-by":"publisher","first-page":"e1000171","DOI":"10.1371\/journal.pcbi.1000171","article-title":"Sizing up allometric scaling theory","volume":"4","author":"Savage","year":"2008","journal-title":"PLoS Comput Biol"},{"key":"key20200713101501_b38-etm-0-0-8129","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/bcp.12649","article-title":"Population pharmacokinetic analysis of tacrolimus in Mexican paediatric renal transplant patients: Role of CYP3A5 genotype and formulation","volume":"80","author":"Jacobo-Cabral","year":"2015","journal-title":"Br J Clin Pharmacol"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2022,10,2]],"date-time":"2022-10-02T15:33:25Z","timestamp":1664724805000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2019.8129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,25]]},"references-count":38,"URL":"https:\/\/doi.org\/10.3892\/etm.2019.8129","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,25]]}}}